MicroRNA Expression in the Glaucomatous Retina
Investigative Ophthalmology & Visual Science
|January 1, 2016
Summary
MicroRNAs are altered in experimental glaucoma, with eight downregulated and one upregulated in damaged retinae. This suggests microRNAs play a role in glaucoma pathogenesis and may offer therapeutic targets.
Area of Science:
- Ophthalmology
- Molecular Biology
- Neuroscience
Background:
- MicroRNAs regulate gene expression post-transcriptionally.
- Evidence from CNS injury suggests microRNAs' role in neurodegeneration.
- The role of microRNAs in glaucoma pathogenesis is currently unknown.
Purpose of the Study:
- To investigate if microRNAs implicated in CNS injury are also altered in experimental glaucoma.
- To identify specific microRNAs dysregulated in glaucomatous retinae.
Main Methods:
- Elevated intraocular pressure (IOP) induced in rats for 5 weeks.
- Optic nerve damage graded, and microRNA extracted from retinae of affected and control eyes.
- Quantitative PCR used for 17 microRNAs; gene targets identified and functionally interpreted.
Main Results:
- Eight microRNAs (miR-181c, miR-497, miR-204, let-7a, miR-29b, miR-16, miR106b, miR-25) were significantly downregulated.
- One microRNA (miR-27a) was significantly upregulated in glaucomatous retinae.
- Enriched targets involved extracellular matrix, immune system, and apoptosis; cholesterol and mTORC-1 pathways showed reduced expression.
Conclusions:
- MicroRNAs are differentially expressed in glaucomatous retinae compared to normal controls.
- Findings indicate microRNAs are involved in the biological response to elevated IOP.
- Integrating microRNA and gene expression data may enhance understanding of glaucoma's complex mechanisms.
